teva-english-logo-gray-web-5
Photo: Courtesy of Teva
16 September 2016Americas

FTC orders biggest ever divestiture in Teva Allergan deal

The US Federal Trade Commission (FTC) has approved a final order that Teva’s acquisition of Allergan’s generic pharmaceutical business for $40.5 billion would be anticompetitive.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
29 March 2017   Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.

More on this story

Americas
29 March 2017   Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.

More on this story

Americas
29 March 2017   Last year was a historic one for the US Federal Trade Commission, according to its “Annual Highlights” report, issued yesterday.